Pulmonary Embolism

EKOS system better than traditional use of clot-buster medications with Dr. Keith Sterling

Dr. Keith M. Sterling joins eHealth Radio to discuss pulmonary embolisms and how the  EKOS system is better than traditional use of clot-buster medications. Dr. Sterling who has been on the medical staff of Inova Alexandria Hospital since 1995.
Listen to interview [audio player below] with host Eric Michaels & guest Dr. Keith Sterling discuss the following:
Dr. Sterling, what is a pulmonary embolism?
You have clearly described a pulmonary embolism but our listening audience needs to understand risk factors in developing a pulmonary embolism.
How is a pulmonary embolism traditionally treated?
From what I understand, there is a better and new interventional approach to dissolving a blood clot or clots that is showing remarkable outcomes.  What would that be?
Dr. Sterling, what makes the EKOS system better than the traditional use of clot-buster medications?
Can you describe a recent patient case where you used EKOS?
What are the typical patient outcomes for patients who are treated with EKOS technology?
Can you offer advice to our listeners regarding how they can reduce their risks of developing a PE?


Dr. Keith M. Sterling has been on the medical staff of Inova Alexandria Hospital since 1995. He earned his medical degree from New York Medical College and completed both an internal medicine internship through Columbia University College of Physicians & Surgeons, and a diagnostic radiology residency at Mount Sinai Medical Center in New York, where he was chief resident.
He went on to a fellowship in vascular and interventional radiology at the Washington University School of Medicine, Mallinckrodt Institute of Radiology, in St. Louis.
Dr. Sterling is board certified in Diagnostic Radiology with a Certificate of Added Qualification in Vascular and Interventional Radiology. He is the Medical Director of the Department of Cardiovascular & Interventional Radiology and has been the principal investigator on numerous interventional drug and device research projects. He has served as President of the Chesapeake Interventional Radiology Society and is a frequently invited lecturer at numerous scientific meetings.

Related Web Site: inova.org